Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Colorectal Neoplasms × spartalizumab × Clear all

Phase

Phase 1 9 Phase 2 6 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 6 Neoplasms 6 Melanoma 5 Neoplasm Metastasis 4 Uterine Cervical Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Liver Neoplasms 2 Glioblastoma 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Sarcoma 1 Salivary Gland Neoplasms 1 Recurrence 1 Pelvic Neoplasms 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Mesothelioma, Malignant 1 Lymphoma 1 Lung Diseases 1 Locally Advanced or Metastatic Solid Tumors 1

Interventions

Cetuximab 39 Irinotecan 33 pembrolizumab 32 Oxaliplatin 32 Bevacizumab 32 Capecitabine 31 Fluorouracil 30 Leucovorin 29 Nivolumab 20 Gemcitabine 13 regorafenib 12 Cyclophosphamide 12 Folfox protocol 11 Cisplatin 10 Pemetrexed 9 Carboplatin 9 tislelizumab 8 Paclitaxel 8 IFL protocol 8 Panitumumab 7 130-nm albumin-bound paclitaxel 7 durvalumab 6 Ipilimumab 6 HMPL-013 6 Drug Therapy 6 irinotecan sucrosofate 5 Trifluridine 5 Specimen Handling 5 Interleukin-2 5 Everolimus 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07365592 2026-01-26

Neo-CD

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡